Clinical trials
Phase 1/2 Fibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Corewell Health East | 1 |
| Devalingam Mahalingam | 1 |
| Hunter Holmes Mcguire Veteran Affairs Medical Center | 1 |
| Regeneron Pharmaceuticals | 1 |
| Retina Research Foundation | 1 |
| Stanford University | 1 |
| Steadman Philippon Research Institute | 1 |
| Synlogic | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 13 |
| Carcinoma, Hepatocellular | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Fatty Liver | 2 |
| Alcoholism | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Gastrointestinal Neoplasms | 1 |
| Glycogen Storage Disease Type II | 1 |
| Graft vs Host Disease | 1 |
| Hepatic Encephalopathy | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.